(AP) – Helicos BioSciences Corp. said Thursday its True Single Molecule Sequencing technology was used to directly sequence individual RNA molecules in a recent study.
The genetic analysis instrument company said the study will appear in a future issue of Nature. The company says True Single Molecule Sequencing is the only commercially available method that can directly sequence RNA molecules without copying their complementary DNA, which can be difficult and create errors.
Helicos said the technology can be used in researching genomes, cancer, common diseases and microbiology.
Its stock price jumped 35 cents, or 14.8 percent, to $2.79. About 9.9 million shares changed hands by 2 p.m. Over the past 100 days, average trading volume for the stock was about 1.4 million shares.
Market Club has a very interesting take on how HLCS is playing out after the past volume surge. The “Trade Triangles” paint the picture. CLICK HERE and just enter the ticker (HLCS) your name and e-mail address for the FREE No strings Attached Report sent realtime to your in-box!
The Market Guardian and Market Club have teamed up to get you 2 FREE MONTHS of Market Clubs Premier Service. Click Here Now, you have nothing to lose and 60 FREE days to gain.
